Aurinia Pharmaceuticals
AUPH
#4815
Rank
ยฃ1.52 B
Marketcap
ยฃ11.37
Share price
-1.59%
Change (1 day)
-2.26%
Change (1 year)

Earnings for Aurinia Pharmaceuticals (AUPH)

Earnings in 2026 (TTM): ยฃ0.12 Billion

According to Aurinia Pharmaceuticals 's latest financial reports the company's current earnings are ยฃ0.32 Billion. In 2025 the company made an earning of ยฃ90.5 Million, an increase over its 2024 earnings that were of ยฃ9.38 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aurinia Pharmaceuticals from 1999 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) ยฃ0.12 B42.08%
2025 ยฃ90.5 M864.64%
2024 ยฃ9.38 M-116.44%
2023 -ยฃ57.06 Million-31.8%
2022 -ยฃ83.66 Million-39.4%
2021 -ยฃ0.14 Billion61.9%
2020 -ยฃ85.27 Million-9.73%
2019 -ยฃ94.46 Million92.65%
2018 -ยฃ49.04 Million36.39%
2017 -ยฃ35.95 Million106.29%
2016 -ยฃ17.43 Million-15.4%
2015 -ยฃ20.6 Million65.84%
2014 -ยฃ12.42 Million129.82%
2013 -ยฃ5.41 Million-26.6%
2012 -ยฃ7.37 Million
2010 -ยฃ4.17 Million-39.22%
2009 -ยฃ6.86 Million-43.78%
2008 -ยฃ12.21 Million-53.19%
2007 -ยฃ26.07 Million42.97%
2006 -ยฃ18.24 Million-23.03%
2005 -ยฃ23.69 Million36.1%
2004 -ยฃ17.41 Million172.57%
2003 -ยฃ6.39 Million484.61%
2002 -ยฃ1.1 Million
2000 -ยฃ5.19 Million453.81%
1999 -ยฃ0.94 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Regeneron Pharmaceuticals
REGN
ยฃ4.34 B 3,225.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Pieris Pharmaceuticals
PIRS
-ยฃ16.9 Million-112.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
-ยฃ4.19 Million-103.21%๐Ÿ‡บ๐Ÿ‡ธ USA